Dr. Vilayvanh Sysounthone
Dr. Vilayvanh Sysounthone, DPM, MS, AACFAS
EDUCATION
D.P.M. received June, 2003.
New York College of Podiatric Medicine, N.Y., N.Y.
M.S. Biology, received May, 1998
Montclair State University, Upper Montclair, New Jersey.
B.A. Biological Sciences/Psychology, received May, 1994
Rutgers College, Rutgers University, New Brunswick, New Jersey.
BOARDS/LICENSING
New Jersey State Licensed Podiatrist
Board qualified in reconstructive rear foot and ankle surgery and foot surgery
CERTIFICATIONS
Application of Illizarov/Taylor Spatial Frame Course 7/28/05
ACFAS: Comprehensive Foot and Ankle Arthroscopy Surgical Skills Course – December 2005
Certified in Shockwave Therapy (ESWT)
AFFILIATIONS
Saint Clare’s Hospital, Dover/Denville/Sussex, NJ
St. Joseph Wayne Hospital – Wayne, NJ
Chilton Memorial Hospital - Pompton Plains, NJ
Hoboken University Medical Center – Hoboken, NJ
East Orange General Hospital - East Orange, NJ
Kindred Hospital - Dover, NJ
The Health Center at Bloomingdale - Bloomingdale, NJ
Emmaus Surgical Center - Hackettstown, NJ
Morris County Surgical Center - Mountain Lakes, NJ
Hackensack Surgery Center - Hackensack, NJ
Surgicare of Englewoodcliffs - Englewoodcliffs, NJ
PROFESSIONAL AFFILIATIONS
Associate of the American College of Foot and Ankle Surgeons
Member of the American Podiatric Medical Association
Member of FAPA
Member of NJPMS
Member of AAWP
PROFESSIONAL EXPERIENCES
UMDNJ – New Jersey Medical School – 185 S. Orange Ave., Newark, NJ 07103 12/97 – 8/99
Research Teaching Specialist III – Department of Medicine/Molecular Oncology
Breast Cancer Research – Molecular/Cellular Biology
PharmaGenics – 4 Pearl Ct., Allendale, NJ 7/95 - 7/97
Associate Investigator (promoted 11/96) – Molecular & Cellular Biology Department
Assistant Investigator (7/95-11/96)
Wyeth-Lederle-Vaccines & Pediatrics – Pearl River, NY 10/97 – 12/97
Associate Scientist – Vaccines & Pediatrics Department – Downstream Processing
UMDNJ – Robert Wood Johnson Medical School – New Brunswick, NJ 8/92 – 1/95
Research Lab Technician – Clinical Research Center – Department of Oncology
Hoffmann La Roche – Kingsland Rd., Nutley, NJ. 1/95 – 5/95
Assistant Scientist – Biopharmaceutical Scale Up and Production Department
LANGUAGES
Spanish, Thai and Laotian.
HONORS & AWARDS
Pi Mu Delta National Podiatry Service Society - 2003
APMA Fund for Podiatric Medical Education Scholarship 2001-2002 and 2002-2003
American Association for Women in Podiatrists, Inc. Award 2002-2003
Pedinol Award for Dermatology 2001 – 2002
NYCPM Student Chapter of AAWP – Year 2000 Book Scholarship Award
Who’s Who Among Students in American Universities & Colleges 2003
All – American Scholars Collegiate Award 2002
Garden State Scholars 1990
PUBLICATIONS/RESEARCH
1. Vilayvanh Sysounthone, F. Ramos, A. ElSaheli. A 12 Month Follow Up on Ostoechondral Talar Defects Treated with Bone Graft Substitute Plugs: Case Studies. Presented at the ACFAS 65th Annual Scientific Conference in Orlando, FL, March 14-18, 2007.
2. Vilayvanh Sysounthone. Puncture Wound From Nail Gun In a Construction Worker. PRESENT Residency Insight Grand Rounds 52, February 2005.
3. Vilayvanh Sysounthone. Puncture Wound From Nail Gun In a Construction Worker, Follow Up. PRESENT Residency Insight Grand Rounds 53, February 2005.
4. Vilayvanh Sysounthone. Unicameral Bone Cyst of the Calcaneus. PRESENT Residency Insight Grand Rounds 19, June 10, 2004.
5. Vilayvanh Sysounthone, Helene Nguyen, Yong Zhu. SINUS TARSI SYNDROME: AN OVERVIEW. PMR Publication, 2003.
6. Vilayvanh Sysounthone. Darrier – White Disease: A Review. PMR Publication, 2002.
7. Q. Wang, D. Lee. V. Sysounthone, R. Chandraratna, S. Christakos, R. Korah and R. Wieder. 1,25-dihydroxyvitamin D3 and Retinoic Acid Analogues Induce Differentiation in Breast Cancer Cells with Function and Cell-Specific Additive Effects. Breast Cancer Research and Treatment 67:157-168, 2001.
8. R. Korah, V. Sysounthone, Y. Golowa, and R. Wieder Basic Fibroblast Growth Factor Confers a Less Malignant Phenotype in MDA-MB-231 Human Breast Cancer Cells. Cancer Research 60:733-740, Feb. 1, 2000.
9. R. Korah, V. Sysounthone, E. Scheff, and R. Wieder. Intracellular FGF-2 Promotes Differentiation in T-47D Breast Cancer Cells. Biochem. & Biophys. Res. Comm. 277:255-260 (2000).
10. V. Sysounthone, A. Lin, R. Wieder and R. Korah. Promotion Of A Less Malignant Phenotype By Basic Fibroblast Growth Factor Expression In Breast Cancer Cells. Presented at the CINJ meeting on May 28, 1999.
11. R. Korah, V. Sysounthone and R. Wieder. Basic FGF Induces Aberrant Focal Adhesion Signaling in Breast Cancer Cells. Presented at the CINJ meeting on May 28, 1999.
12. R. Wieder, V. Sysounthone, R. Korah. Basic fibroblast growth factor promotes a less malignant phenotype, microtubule dissociation and focal adhesion kinase dephosphorylation in breast cancer cells. Accepted for presentation on May 1999 at the ASCO meeting.
13. Korah, R., Golowa, Y., Sysounthone, V., Wieder, R. Expression of basic fibroblast growth factor (bFGF) induces a less malignant phenotype in human breast cancer cells. Accepted for presentation on April 14, 1999 at the AACR meeting.
14. Vilayvanh Sysounthone, Purvi Patel and Thresia Thomas, Growth Inhibitory and Apoptotic Effects of RU486 on MCF-7 and T-47D Breast Cancer Cells. Accepted for presentation at the 1994 Annual Meeting of the Endocrine Society.
15. Sysounthone, V., Thomas, T., Faaland, C., Thomas, T.J. Inactivation of the cell cycle inhibitory protein, p21 (CIP1/WAF1) during chemical carcinogenesis of normal breast epithelial cells. Accepted for presentation on 15 March 1995 at the American Association of Cancer Research (AACR) Meeting.
